Surgery Partners [SGRY] vs DaVita [DVA] Detailed Stock Comparison
Surgery Partners
NASDAQ
Loading...
DaVita
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Surgery Partners wins in 3 metrics, DaVita wins in 16 metrics, with 0 ties. DaVita appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Surgery Partners | DaVita | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 2,956.00 | 12.92 | DaVita |
| Price-to-Book Ratio | 1.54 | 6.41 | Surgery Partners |
| Debt-to-Equity Ratio | 108.74 | 825.19 | Surgery Partners |
| PEG Ratio | -35.47 | 5.51 | Surgery Partners |
| EV/EBITDA | 12.66 | 8.70 | DaVita |
| Profit Margin (TTM) | -5.57% | 6.35% | DaVita |
| Operating Margin (TTM) | 14.68% | 15.70% | DaVita |
| EBITDA Margin (TTM) | 14.68% | 15.70% | DaVita |
| Return on Equity | 0.12% | 57.94% | DaVita |
| Return on Assets (TTM) | 3.92% | 7.15% | DaVita |
| Free Cash Flow (TTM) | $209.70M | $1.47B | DaVita |
| 1-Year Return | -33.06% | -20.34% | DaVita |
| Price-to-Sales Ratio (TTM) | 0.84 | 0.71 | DaVita |
| Enterprise Value | $8.17B | $23.38B | DaVita |
| EV/Revenue Ratio | 2.52 | 1.78 | DaVita |
| Gross Profit Margin (TTM) | 23.67% | 33.08% | DaVita |
| Revenue per Share (TTM) | $26 | $164 | DaVita |
| Earnings per Share (Diluted) | $-1.43 | $10.15 | DaVita |
| Beta (Stock Volatility) | 1.84 | 1.12 | DaVita |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Surgery Partners vs DaVita Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Surgery Partners | -3.59% | -6.94% | -7.65% | -7.44% | -0.59% | -4.23% |
| DaVita | -2.30% | -1.88% | -4.74% | -10.27% | -12.60% | -14.47% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Surgery Partners | -33.06% | -17.62% | -13.75% | 7.49% | 10.63% | 10.63% |
| DaVita | -20.34% | 43.35% | 41.15% | 67.50% | 254.47% | 430.16% |
News Based Sentiment: Surgery Partners vs DaVita
Surgery Partners
News based Sentiment: NEUTRAL
Surgery Partners reported solid revenue growth and reaffirmed its guidance, but profitability remains a concern. Regulatory changes introduce both opportunities and challenges, creating a balanced investment picture. The upcoming Investor Day will be crucial for clarifying the company's strategy and outlook.
DaVita
News based Sentiment: MIXED
October was a mixed month for DaVita, marked by a significant cybersecurity incident that created immediate operational and financial risks. However, positive analyst ratings, inclusion in Warren Buffett's portfolio, and indications of undervaluation suggest potential long-term value, creating a complex investment picture.
Performance & Financial Health Analysis: Surgery Partners vs DaVita
| Metric | SGRY | DVA |
|---|---|---|
| Market Information | ||
| Market Cap | $2.80B | $9.39B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,195,740 | 638,480 |
| 90 Day Avg. Volume | 1,294,510 | 791,187 |
| Last Close | $20.39 | $128.14 |
| 52 Week Range | $18.87 - $33.37 | $126.07 - $179.60 |
| % from 52W High | -38.90% | -28.65% |
| All-Time High | $69.58 (Jun 21, 2021) | $179.60 (Jan 27, 2025) |
| % from All-Time High | -70.70% | -28.65% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.06% |
| Quarterly Earnings Growth | 0.08% | -0.11% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | 0.06% |
| Operating Margin (TTM) | 0.15% | 0.16% |
| Return on Equity (TTM) | 0.00% | 0.58% |
| Debt to Equity (MRQ) | 108.74 | 825.19 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.73 | $-4.98 |
| Cash per Share (MRQ) | $1.96 | $10.34 |
| Operating Cash Flow (TTM) | $263.90M | $1.86B |
| Levered Free Cash Flow (TTM) | $162.32M | $1.10B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Surgery Partners vs DaVita
| Metric | SGRY | DVA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 2,956.00 | 12.92 |
| Forward P/E | 16.79 | 11.64 |
| PEG Ratio | -35.47 | 5.51 |
| Price to Sales (TTM) | 0.84 | 0.71 |
| Price to Book (MRQ) | 1.54 | 6.41 |
| Market Capitalization | ||
| Market Capitalization | $2.80B | $9.39B |
| Enterprise Value | $8.17B | $23.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.52 | 1.78 |
| Enterprise to EBITDA | 12.66 | 8.70 |
| Risk & Other Metrics | ||
| Beta | 1.84 | 1.12 |
| Book Value per Share (MRQ) | $13.73 | $-4.98 |
Financial Statements Comparison: Surgery Partners vs DaVita
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SGRY | DVA |
|---|---|---|
| Revenue/Sales | $776.00M | $3.22B |
| Cost of Goods Sold | $614.10M | $2.24B |
| Gross Profit | $161.90M | $983.87M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $89.60M | $433.33M |
| EBITDA | $131.50M | $597.84M |
| Pre-Tax Income | $-300,000 | $286.33M |
| Income Tax | $0 | $54.12M |
| Net Income (Profit) | $-300,000 | $232.22M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SGRY | DVA |
|---|---|---|
| Cash & Equivalents | $229.30M | $438.78M |
| Total Current Assets | $1.07B | $3.64B |
| Total Current Liabilities | $569.40M | $2.91B |
| Long-Term Debt | $3.72B | $11.72B |
| Total Shareholders Equity | $3.59B | $1.66B |
| Retained Earnings | $-775.00M | $1.70B |
| Property, Plant & Equipment | $2.02B | $11.65B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SGRY | DVA |
|---|---|---|
| Operating Cash Flow | $-1.50M | $287.94M |
| Capital Expenditures | $-17.90M | $-143.26M |
| Free Cash Flow | $-16.70M | $36.75M |
| Debt Repayment | $-119.30M | $-345.97M |
| Common Stock Repurchase | N/A | $-541.85M |
Short Interest & Institutional Ownership Analysis
| Metric | SGRY | DVA |
|---|---|---|
| Shares Short | 13.22M | 7.51M |
| Short Ratio | 10.18 | 10.82 |
| Short % of Float | 0.22% | 0.21% |
| Average Daily Volume (10 Day) | 1,195,740 | 638,480 |
| Average Daily Volume (90 Day) | 1,294,510 | 791,187 |
| Shares Outstanding | 127.11M | 80.54M |
| Float Shares | 68.52M | 35.69M |
| % Held by Insiders | 0.01% | 0.50% |
| % Held by Institutions | 1.14% | 0.52% |
Dividend Analysis & Yield Comparison: Surgery Partners vs DaVita
| Metric | SGRY | DVA |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |